Testing blood/brain marker levels and thinking problems in psychiatric illness
Part of Brain & nervous system, Mental health clinical trials.
This study looks at neurofilament light (a brain/nerve injury marker) and how it relates to thinking and memory problems in people with certain psychiatric conditions. It may help researchers understand brain changes and cognitive impairment, which could guide better diagnosis in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to give written consent
- You are between 45 and 80 years old
- You have one of these diagnoses: schizophrenia or bipolar disorder, OR you have probable/definite frontotemporal dementia, OR “biological” Alzheimer’s disease based on typical spinal fluid results
- You can complete interviews/history (you’re reachable and information is available)
- You do NOT have a past stroke, serious brain bleed, or major head injury with loss of consciousness
- You do NOT have long-term heavy alcohol/drug use, a severe uncontrolled medical condition, or poorly controlled epilepsy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood tests to help diagnose and track brain diseases (like Alzheimer's) or mental health conditions. It compares patients to healthy volunteers to find better ways to detect and monitor these illnesses.
This study looks at how social factors and blood markers relate to psychiatric symptoms in people with brain diseases or mental disorders. It aims to find new ways to understand and diagnose these conditions.
This study looks at how psychiatric and neurological conditions affect thinking and memory skills. By comparing patients with healthy volunteers, researchers hope to better understand these cognitive problems and find new ways to help.
This trial looks at how blood biomarkers relate to thinking, daily function, and survival in older adults, including those with neurological issues or dementia. It aims to improve understanding and care for hospitalized seniors.
This study is testing whether simple blood tests can help doctors better understand the type and progression of memory or thinking problems in people with early dementia. It aims to improve confidence in the diagnosis and future outlook.
This study is testing whether a simple blood test can help diagnose Alzheimer's disease and predict how the disease will progress. If you have memory or thinking problems that have been getting worse, you may be able to join.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.